85 related articles for article (PubMed ID: 8714623)
1. Prevalence of antibody to hepatitis C virus in Pakistani thalassaemics by particle agglutination test utilizing C 200 and C 22-3 viral antigen coated particles.
Bhatti FA; Amin M; Saleem M
J Pak Med Assoc; 1995 Oct; 45(10):269-71. PubMed ID: 8714623
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan.
Kakepoto GN; Bhally HS; Khaliq G; Kayani N; Burney IA; Siddiqui T; Khurshid M
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):703-6. PubMed ID: 9253870
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
[TBL] [Abstract][Full Text] [Related]
5. Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients.
Ansari SH; Shamsi TS; Khan MT; Perveen K; Farzana T; Erum S; Ansari I
J Coll Physicians Surg Pak; 2012 Sep; 22(9):610-1. PubMed ID: 22980623
[TBL] [Abstract][Full Text] [Related]
6. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
7. Determination of alanine aminotransferase in blood donor screening--evidence of its usefulness in the prevention of post-transfusion hepatitis.
Khouri ST; Lopes EP; Perez RM; Figueiredo VM; Lanzoni VP; Silva AE; Ferraz ML
Clin Lab; 2004; 50(5-6):291-4. PubMed ID: 15209437
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand.
Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298
[TBL] [Abstract][Full Text] [Related]
9. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions.
Bruhn R; Lelie N; Busch M; Kleinman S;
Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of HBV and HCV infections in plasma donors with recently increased ALT level].
Li F
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):217-9. PubMed ID: 7511485
[TBL] [Abstract][Full Text] [Related]
11. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
12. Frequency of hepatitis C viral RNA in anti-hepatitis C virus non- reactive blood donors with raised alanine aminotransferase.
Ali N; Ahmed SA; Moinuddin ; Hoch SF; Chotani RA
J Coll Physicians Surg Pak; 2011 Dec; 21(12):782-3. PubMed ID: 22166707
[TBL] [Abstract][Full Text] [Related]
13. Antibody to hepatitis-C virus in multi-transfused thalassaemics--Indian experience.
Agarwal MB; Malkan GH; Bhave AA; Vishwanathan C; Billa V; Dube SR; Bajan K; Rajadhyaksha GC; Shah SH
J Assoc Physicians India; 1993 Apr; 41(4):195-7. PubMed ID: 8270554
[TBL] [Abstract][Full Text] [Related]
14. Identifying hepatitis C virus: endemic areas and estimating the viral antibody prevalence based on the prevalence of ALT elevation.
Chiang JC; Lin CY; Wang JH; Kee KM; Chen PF; Chen YD; Tsai LS; Chen TH; Lu SN
Trans R Soc Trop Med Hyg; 2009 Sep; 103(9):917-23. PubMed ID: 19403151
[TBL] [Abstract][Full Text] [Related]
15. Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors.
Cable R; Badon S; Pray C; Popovsky MA
Transfusion; 1997 Feb; 37(2):206-10. PubMed ID: 9051097
[TBL] [Abstract][Full Text] [Related]
16. Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors.
Acquaye JK; Tettey-Donkor D
West Afr J Med; 2000; 19(4):239-41. PubMed ID: 11391831
[TBL] [Abstract][Full Text] [Related]
17. General seroprevalence of hepatitis C and hepatitis B virus infections in population.
Khokhar N; Gill ML; Malik GJ
J Coll Physicians Surg Pak; 2004 Sep; 14(9):534-6. PubMed ID: 15353136
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and C infection: is it a problem in Polish healthcare workers?
Rybacki M; Piekarska A; Wiszniewska M; Walusiak-Skorupa J
Int J Occup Med Environ Health; 2013 Jun; 26(3):430-9. PubMed ID: 23817869
[TBL] [Abstract][Full Text] [Related]
19. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
